• Tue, February 2, 2021

by: WOPRAI

Adam Jonas Maintained (TSLA) at Buy with Increased Target to $293 on, Feb 2nd, 2021

by: WOPRAI

Josh Beck Maintained (BILL) at Buy with Increased Target to $150 on, Feb 2nd, 2021

by: WOPRAI

Josh Beck Maintained (BL) at Buy with Increased Target to $145 on, Feb 2nd, 2021

by: WOPRAI

Patrick Walravens Maintained (BL) at Buy with Increased Target to $163 on, Feb 2nd, 2021

by: WOPRAI

Brian Abrahams Maintained (VRTX) at Buy and Held Target at $264 on, Feb 2nd, 2021

by: WOPRAI

Ben Davis Downgraded (BHP) to Strong Sell on, Feb 2nd, 2021

by: WOPRAI

Carsten Riek Downgraded (BHP) to Hold on, Feb 2nd, 2021

by: WOPRAI

Max Masucci Maintained (BDSX) at Strong Buy with Increased Target to $31 on, Feb 2nd, 2021

by: WOPRAI

George Galliers Initiated (STLA) at Strong Buy on, Feb 2nd, 2021

by: WOPRAI

Stephen Byrd Maintained (SR) at Hold with Increased Target to $69 on, Feb 2nd, 2021

by: WOPRAI

Michael Weinstein Maintained (SR) at Buy with Decreased Target to $69 on, Feb 2nd, 2021

by: WOPRAI

Jimmy Bhullar Initiated (ALL) at Buy and Held Target at $127 on, Feb 2nd, 2021

by: WOPRAI

Itay Michaeli Maintained (ALV) at Hold with Increased Target to $97 on, Feb 2nd, 2021

by: WOPRAI

Tej Sthankiya Maintained (ACN) at Strong Buy with Increased Target to $285 on, Feb 2nd, 2021

by: WOPRAI

John Vinh Maintained (CRUS) at Buy with Increased Target to $110 on, Feb 2nd, 2021

by: WOPRAI

Anthony Stoss Downgraded (CRUS) to Hold and Held Target at $80 on, Feb 2nd, 2021

by: WOPRAI

Ruben Roy Maintained (CRUS) at Strong Buy with Increased Target to $105 on, Feb 2nd, 2021

by: WOPRAI

Matthew Ramsay Maintained (CRUS) at Buy with Increased Target to $115 on, Feb 2nd, 2021

by: WOPRAI

Michael Zaremski Maintained (TRV) at Hold with Increased Target to $142 on, Feb 2nd, 2021

by: WOPRAI

Toni Kaplan Initiated (TRI) at Hold and Held Target at $93 on, Feb 2nd, 2021

by: WOPRAI

Kimberly Greenberger Maintained (TPR) at Hold with Increased Target to $23 on, Feb 2nd, 2021

by: WOPRAI

Jason Bednar Maintained (ALGN) at Buy with Increased Target to $610 on, Feb 2nd, 2021

by: WOPRAI

Sandeep Deshpande Maintained (ASML) at Buy with Increased Target to $640 on, Feb 2nd, 2021

by: WOPRAI

Joseph Giordano Maintained (TEL) at Buy with Increased Target to $140 on, Feb 2nd, 2021

by: WOPRAI

Edward Tenthoff Downgraded (ARGX) to Hold and Increased Target to $303 on, Feb 2nd, 2021

by: WOPRAI

Yanan Zhu Maintained (ARGX) at Hold with Increased Target to $326 on, Feb 2nd, 2021

by: WOPRAI

Gregg Gilbert Maintained (ARQT) at Strong Buy with Increased Target to $48 on, Feb 2nd, 2021

by: WOPRAI

Brad Erickson Maintained (ZG) at Strong Buy with Increased Target to $175 on, Feb 2nd, 2021

by: WOPRAI

Brad Erickson Maintained (Z) at Strong Buy with Increased Target to $175 on, Feb 2nd, 2021

by: WOPRAI

Benjamin Swinburne Maintained (WMG) at Buy with Increased Target to $42 on, Feb 2nd, 2021

by: WOPRAI

Ashish Sabadra Maintained (WSC) at Strong Buy with Increased Target to $26 on, Feb 2nd, 2021

by: WOPRAI

Geoffrey Porges Maintained (VRTX) at Hold with Decreased Target to $250 on, Feb 2nd, 2021

by: WOPRAI

Evan Seigerman Maintained (VRTX) at Buy with Decreased Target to $280 on, Feb 2nd, 2021

by: WOPRAI

Do Kim Maintained (VRTX) at Buy with Decreased Target to $284 on, Feb 2nd, 2021

by: WOPRAI

Edward Tenthoff Maintained (VRTX) at Buy with Increased Target to $347 on, Feb 2nd, 2021

by: WOPRAI

Tim Nollen Maintained (TTD) at Buy with Increased Target to $90 on, Feb 2nd, 2021

by: WOPRAI

James West Upgraded (TTI) to Buy and Held Target at $3 on, Feb 2nd, 2021

by: WOPRAI

Matthew Thornton Maintained (TTWO) at Strong Buy with Increased Target to $220 on, Feb 2nd, 2021

by: WOPRAI

Peter Heckmann Maintained (TYL) at Hold with Increased Target to $370 on, Feb 2nd, 2021

by: WOPRAI

Robert Spingarn Maintained (WWD) at Buy with Increased Target to $147 on, Feb 2nd, 2021

by: WOPRAI

Buck Horne Maintained (WY) at Buy with Increased Target to $37 on, Feb 2nd, 2021

by: WOPRAI

Michael Swartz Maintained (THO) at Strong Buy with Increased Target to $135 on, Feb 2nd, 2021

by: WOPRAI

Puneet Souda Maintained (TMO) at Buy with Increased Target to $560 on, Feb 2nd, 2021

by: WOPRAI

Tejas Savant Maintained (TMO) at Buy with Increased Target to $575 on, Feb 2nd, 2021

by: WOPRAI

Daniel Arias Maintained (TMO) at Strong Buy with Increased Target to $600 on, Feb 2nd, 2021

by: WOPRAI

Doug Schenkel Maintained (TMO) at Buy with Increased Target to $585 on, Feb 2nd, 2021

by: WOPRAI

Dan Brennan Maintained (TMO) at Strong Buy with Increased Target to $588 on, Feb 2nd, 2021

by: WOPRAI

Patrick Donnelly Maintained (TMO) at Strong Buy with Increased Target to $530 on, Feb 2nd, 2021

Gregg Gilbert Maintained (ARQT) at Strong Buy with Increased Target to $48 on, Feb 2nd, 2021

Gregg Gilbert of Truist Securities, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy with Increased Target from $38 to $48 on, Feb 2nd, 2021.

Gregg has made no other calls on ARQT in the last 4 months.



There are 2 other peers that have a rating on ARQT. Out of the 2 peers that are also analyzing ARQT, 0 agree with Gregg's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Gregg

  • Ken Cacciatore of "Cowen & Co." Maintained at Buy with Increased Target to $80 on, Monday, February 1st, 2021
  • Graig Suvannavejh of "Goldman Sachs" Upgraded from Hold to Strong Buy and Held Target at $36 on, Monday, November 9th, 2020